Association between biomarkers and disease often overstated, Stanford researcher finds
STANFORD, Calif. — More than two dozen widely cited studies linking genes or other "biomarkers" to specific diseases vastly overstate the association, according to new research from an expert in scientific study design at the Stanford University School of Medicine. As a result, clinicians may be making decisions for their patients based on inaccurate conclusions not supported by other, larger studies.
The widely cited studies include one linking the BRCA1 mutation with colon cancer, another that links levels of C-reactive protein in the blood with cardiovascular disease ...








